MedTrace Logo

Study On The Performance And Safety Of The REVISYON SDS 100 Device On Visual Acuity In Subjects With Cataract

NCT05396547 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2025-11-24

No results posted yet for this study

Summary

Single arm, unmasked study to evaluate the performance and safety of the REVISYON SDS 100 Device for the non-invasive treatment of vision loss in age-related cataract.

Conditions

  • Age-related Cataract

Interventions

DEVICE

Treated with REVISYON SDS 100 Device

Treated with REVISYON SDS 100 Device

Sponsors & Collaborators

  • MDX Research

    collaborator NETWORK

  • Edinburgh Biosciences Ltd

    lead INDUSTRY

Principal Investigators

  • Trevor Shields · Edinburgh Biosciences Ltd

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-28
Primary Completion
2025-01-04
Completion
2025-02-02

Countries

  • Latvia
  • Lithuania
  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05396547 on ClinicalTrials.gov